Medicines Development For Global Health

This large study aims to see if a new combination of medicines (MoxDA) works better and is as safe as the current standard (IDA) for controlling three parasitic infections: lymphatic filariasis, scabies, and strongyloidiasis. About 5,100 children and adults in Fijian communities …

This study is testing an unapproved drug called dovramilast to see if it can better control painful skin flare-ups caused by leprosy type 2 reaction. It will compare two doses of the new drug against current standard treatments over 12 weeks in 45 adults. The main goal is to see …